Trials / Withdrawn
WithdrawnNCT02151123
Metabiomics Colon Cancer Clinical Research Study
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Metabiomics Corp · Industry
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The specific aim of the study is to determine the false negative rate of the Metabiomics Colon Polyp and Colorectal Cancer Assay for Cancer.
Detailed description
The purpose of this study is to conduct clinical research to investigate the association of the gut microbiome with colonic neoplasia. In this case several types of gut microbiome samples will be collected from patients undergoing colectomy for colonic adenocarcinoma; those samples will be tested by Metabiomics Colon Polyp and Colorectal Cancer Assay and the percentage of false negative (test returns a negative for cancer) results determined.
Conditions
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2020-03-01
- Completion
- 2020-09-01
- First posted
- 2014-05-30
- Last updated
- 2025-09-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02151123. Inclusion in this directory is not an endorsement.